Chee Wee Ong

2.3k total citations
35 papers, 1.5k citations indexed

About

Chee Wee Ong is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chee Wee Ong has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chee Wee Ong's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Cells and Metastasis (5 papers) and Prostate Cancer Treatment and Research (5 papers). Chee Wee Ong is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Cells and Metastasis (5 papers) and Prostate Cancer Treatment and Research (5 papers). Chee Wee Ong collaborates with scholars based in Singapore, United Kingdom and United States. Chee Wee Ong's co-authors include Manuel Salto‐Tellez, Benedict Yan, Supriya Srivastava, Richie Soong, Brendan Pang, Khay Guan Yeoh, Kol Jia Yong, Barry Iacopetta, Yoshiaki Ito and Darragh G. McArt and has published in prestigious journals such as New England Journal of Medicine, Cancer Research and Oncogene.

In The Last Decade

Chee Wee Ong

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chee Wee Ong Singapore 21 845 688 338 314 179 35 1.5k
M. Ratcliffe United Kingdom 20 619 0.7× 680 1.0× 411 1.2× 661 2.1× 198 1.1× 47 1.6k
Zhenfang Du China 15 776 0.9× 404 0.6× 227 0.7× 279 0.9× 105 0.6× 34 1.3k
Andrea Malfettone Spain 23 705 0.8× 664 1.0× 358 1.1× 321 1.0× 206 1.2× 53 1.5k
Lynne Reid Australia 22 664 0.8× 555 0.8× 487 1.4× 193 0.6× 102 0.6× 29 1.4k
Katrin E. Tagscherer Germany 22 897 1.1× 564 0.8× 368 1.1× 227 0.7× 181 1.0× 46 1.5k
Armelle Degeorges France 18 747 0.9× 776 1.1× 562 1.7× 404 1.3× 117 0.7× 34 1.6k
John S. Yordy United States 18 788 0.9× 605 0.9× 353 1.0× 346 1.1× 97 0.5× 32 1.5k
Simonetta Buglioni Italy 22 930 1.1× 772 1.1× 511 1.5× 227 0.7× 188 1.1× 71 1.7k
Peter Horak Germany 20 1.2k 1.5× 457 0.7× 590 1.7× 242 0.8× 235 1.3× 68 1.9k
Charles D. Lopez United States 23 987 1.2× 1.0k 1.5× 375 1.1× 223 0.7× 201 1.1× 97 1.8k

Countries citing papers authored by Chee Wee Ong

Since Specialization
Citations

This map shows the geographic impact of Chee Wee Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee Wee Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee Wee Ong more than expected).

Fields of papers citing papers by Chee Wee Ong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee Wee Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee Wee Ong. The network helps show where Chee Wee Ong may publish in the future.

Co-authorship network of co-authors of Chee Wee Ong

This figure shows the co-authorship network connecting the top 25 collaborators of Chee Wee Ong. A scholar is included among the top collaborators of Chee Wee Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee Wee Ong. Chee Wee Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Lui Shiong, Adelene Y. L. Sim, Chee Wee Ong, et al.. (2022). NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer. Prostate Cancer and Prostatic Diseases. 25(4). 741–748. 14 indexed citations
2.
Ong, Chee Wee, et al.. (2020). Breast Cancer Classification: A CAD System for a Combined Use of Elastography and B-Mode Sonography. 7(1). 1–6. 3 indexed citations
3.
Chan, Jason Yongsheng, Joe Yeong, Chee Wee Ong, et al.. (2020). 427P On the clinical implications of systemic and local immune responses in human angiosarcoma. Annals of Oncology. 31. S1409–S1409. 1 indexed citations
4.
McCann, Christopher, Nyree Crawford, Joanna Majkut, et al.. (2018). Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists. Cell Death and Disease. 9(11). 1081–1081. 12 indexed citations
5.
Maxwell, Perry, Melissa J. LaBonte, Chee Wee Ong, et al.. (2017). Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer. Annals of Oncology. 28. v8–v9.
6.
Dunne, Philip D., Sonali Dasgupta, Jaine K. Blayney, et al.. (2015). EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer. Clinical Cancer Research. 22(1). 230–242. 108 indexed citations
7.
Bingham, Victoria, Chee Wee Ong, Jacqueline A. James, et al.. (2015). PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry. Human Pathology. 47(1). 95–103. 17 indexed citations
8.
Khin, Lay Wai, Benedict Yan, Chee Wee Ong, et al.. (2014). Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian Population. Clinical and Translational Gastroenterology. 5(2). e51–e51. 34 indexed citations
9.
Dunne, Philip D., Darragh G. McArt, Jaine K. Blayney, et al.. (2013). AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer. Clinical Cancer Research. 20(1). 164–175. 89 indexed citations
10.
Yong, Kol Jia, Chong Gao, Joline S.J. Lim, et al.. (2013). Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma. New England Journal of Medicine. 368(24). 2266–2276. 198 indexed citations
11.
Pang, Brendan, Chee Wee Ong, Seema Gupta, et al.. (2012). The positive impact of cytological specimens for EGFR mutation testing in non‐small cell lung cancer: a single South East Asian laboratory’s analysis of 670 cases. Cytopathology. 23(4). 229–236. 39 indexed citations
12.
Ong, Chee Wee, et al.. (2012). Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer. Oncogene. 32(12). 1488–1496. 39 indexed citations
13.
Chan, Jason Yongsheng, Chee Wee Ong, & Manuel Salto‐Tellez. (2011). Overexpression of neurone glial‐related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer. Cancer Science. 102(10). 1855–1861. 18 indexed citations
14.
Huang, Bo, Zhaoxia Qu, Chee Wee Ong, et al.. (2011). RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α. Oncogene. 31(4). 527–534. 62 indexed citations
15.
Yan, Benedict, Chee Wee Ong, Kol Jia Yong, et al.. (2011). Clinical and therapeutic relevance of PIM1 kinase in gastric cancer. Gastric Cancer. 15(2). 188–197. 37 indexed citations
16.
17.
Yan, Benedict, Supriya Srivastava, Chee Wee Ong, et al.. (2011). Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumours. Journal of Clinical Pathology. 64(12). 1097–1101. 25 indexed citations
18.
Wang, Timothy C., Chee Wee Ong, Jie Shi, et al.. (2011). Sequential expression of putative stem cell markers in gastric carcinogenesis. British Journal of Cancer. 105(5). 658–665. 94 indexed citations
19.
Ong, Chee Wee, et al.. (2010). CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Modern Pathology. 23(3). 450–457. 140 indexed citations
20.
Yan, Benedict, et al.. (2010). A study of HER2 gene amplification and protein expression in gastric cancer. Journal of Clinical Pathology. 63(9). 839–842. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Ratcliffe Breakdown of academic impact, for papers by Zhenfang Du Breakdown of academic impact, for papers by Andrea Malfettone Breakdown of academic impact, for papers by Lynne Reid Breakdown of academic impact, for papers by Katrin E. Tagscherer Breakdown of academic impact, for papers by Armelle Degeorges Breakdown of academic impact, for papers by John S. Yordy Breakdown of academic impact, for papers by Simonetta Buglioni Breakdown of academic impact, for papers by Peter Horak Breakdown of academic impact, for papers by Charles D. Lopez
Rankless by CCL
2026